Increased risk for group b streptococcus sepsis in young infants exposed to hiv, soweto, south africa, 2004–20081

Emerging Infectious Diseases

Volumn 21, Issue 4, 2015, Pages 638-645

  Cutland, Clare L ^a,b   Schrag, Stephanie J ^c   Thigpen, Michael C ^c   Velaphi, Sithembiso C ^a,d   Wadula, Jeannette ^a,d   Adrian, Peter V ^a,b   Kuwanda, Locadiah ^a,b   Groome, Michelle J ^a,b   Buchmann, Eckhart ^a,d   Madhi, Shabir A ^a,b,e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; GENTAMICIN; NEVIRAPINE; PENICILLIN DERIVATIVE; STREPTOCOCCUS VACCINE; TRIPLE VACCINE;

ANTIBIOTIC SENSITIVITY; ANTIVIRAL THERAPY; ARTICLE; BACTEREMIA; BLOOD CELL COUNT; BLOOD CULTURE; CHORIOAMNIONITIS; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GROUP B STREPTOCOCCAL INFECTION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INCIDENCE; INFANT; LATEX AGGLUTINATION TEST; LOW BIRTH WEIGHT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MENINGITIS; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PREMATURITY; PREVALENCE; SEROTYPING; SINGLE DRUG DOSE; SOUTH AFRICA; VACCINATION; AGE; CHILD; CLASSIFICATION; DRUG EFFECTS; HEALTH SURVEY; HISTORY; HIV INFECTIONS; IMMUNOLOGY; MICROBIAL SENSITIVITY TEST; MIXED INFECTION; MORTALITY; PRESCHOOL CHILD; RISK; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; COINFECTION; HISTORY, 21ST CENTURY; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MORTALITY; POPULATION SURVEILLANCE; PREVALENCE; RISK; SEPSIS; SEROTYPING; SOUTH AFRICA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE;

EID: 84924980189     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2104.141562     Document Type: Article

References (35)

1. Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:957–79. http://dx.doi.org/10.1016/S0140-6736(14)60497-9
2. Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA, et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, South Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:731–41. http://dx.doi.org/10.1016/S1473-3099(14)70804-7
3. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379:547–56. http://dx.doi.org/10.1016/S0140-6736(11)61651-6
4. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012;55:91–102. http://dx.doi.org/10.1093/cid/cis395
5. Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28(Suppl):S10–8. http://dx.doi.org/10.1097/INF.0b013e3181958769
6. Kwatra GC, Cunnington M, Valencia C, Adrian PV, Ip M, Klugman K, Madhi SA, et al. Maternal colonization with group B Streptococcus: do rates vary across regions? In: Abstracts of the 8th World Congress of World Society for Pediatric Infectious Diseases; Cape Town, South Africa. 2013 Nov 19–22. Abstract P-291. Geneva: Kenes International; 2013.
7. Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009;374:1909–16. http://dx.doi.org/10.1016/S0140-6736(09)61339-8
8. Gray KJ, Kafulafula G, Matemba M, Kamdolozi M, Membe G, French N, et al. Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008–2010. Emerg Infect Dis. 2011;17:1932–5. http://dx.doi.org/10.3201/eid1710.102008
9. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299:2056–65. http://dx.doi.org/10.1001/jama.299.17.2056
10. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev. 2014;6:CD007467.
11. Statistics South Africa. Mid-year population estimates, 2013 [cited 2014 Jul 28]. http://beta2.statssa.gov.za/?page_id=1854&PPN=P0302&SCH=5500
12. Republic of South Africa. National Health Act, 2004. Government Gazette. 2003;469, no. 61 [cited 2014 Jul 18]. http://www.health.gov.za/docs/acts/2004/a61-03.pdf
13. National Coordinating Committee for the Millennium Development Goals. Millenium development goals, country report 2013 [cited 2014 Jul 29]. http://beta2.statssa.gov.za/MDG/MDGR_2013.pdf
14. Department of Health. South Africa. Progress report on declaration of commitment on HIV and AIDS, Republic of South Africa. 2008 [cited 2014 Jul 18]. http://www.gov.za/sites/www.gov.za/files/prog-rpt_hiv-aids_0607.pdf
15. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal–newborn dyads. PLoS ONE. 2011;6:e17861. http://dx.doi.org/10.1371/journal.pone.0017861
16. Schrag SJ, Cutland CL, Zell ER, Kuwanda L, Buchmann EJ, Velaphi SC, et al. Risk factors for neonatal sepsis and perinatal death among infants enrolled in the Prevention of Perinatal Sepsis Trial, Soweto, South Africa. Pediatr Infect Dis J. 2012;31:821–6. http://dx.doi.org/10.1097/INF.0b013e31825c4b5a
17. Statistics South Africa. Recorded live births, 2012 [cited 2014 Jul 29]. http://beta2.statssa.gov.za/?page_id=1854&PPN =P0305&SCH=5604
18. Department of Health. Republic of South Africa. The 2011 National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa [cited 2014 Jul 29]. http://www.health-e.org.za/wp-content/uploads/2013/05/f0980fb5107a7ce543a8bd5730e52333.pdf
19. Heyderman R, French N, Madhi SA, Cutland CL, Ngwira B, Mboizi R, et al. Safety and immunogenicity of investigational group B Streptococcus trivalent polysaccharide-conjugate vaccine in HIV-infected and uninfected pregnant African women and newborns [cited 2015 Feb 11]. In: Abstracts of the 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases; May 6–10, 2014; Dublin Ireland; 2014. Abstract ESPID-1120. http://espid2015.kenes.com/PublishingImages/scientific-information/espid-abstracts/ESPID%202014%20abstracts.pdf
20. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11:497–513.
21. Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G, Mokhachane M, et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003;23:15–23. http://dx.doi.org/10.1179/000349803125002814
22. Haffejee IE, Bhana RH, Coovadia YM, Hoosen AA, Marajh AV, Gouws E. Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa. J Infect. 1991;22:225–31. http://dx.doi.org/10.1016/S0163-4453(05)80003-9
23. Darmstadt GL, Saha SK, Choi Y, El Arifeen S, Ahmed NU, Bari S, et al. Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis. 2009;200:906–15. http://dx.doi.org/10.1086/605473
24. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics. 2010;126:e631–8. http://dx.doi.org/10.1542/peds.2010-0183
25. Cutland CL, Schrag SJ, Zell ER, Kuwanda L, Buchmann E, Velaphi SC, et al. Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics. 2012;130:e581–90. http://dx.doi.org/10.1542/peds.2011-1548
26. Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, et al. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int J Epidemiol. 1995;24:1022–9. http://dx.doi.org/10.1093/ije/24.5.1022
27. Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013;91:70–4. http://dx.doi.org/10.2471/BLT.12.106807
28. Dangor Z, Kwatra G, Izu A, Lala SG, Madhi SA. Review on the association of group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines. 2015;14:135–49. http://dx.doi.org/10.1586/14760584.2014.953939
29. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305:576–84. http://dx.doi.org/10.1001/jama.2011.100
30. Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, et al. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014;28:531–41. http://dx.doi.org/10.1097/QAD.0000000000000127
31. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176:11–22. http://dx.doi.org/10.1111/cei.12251
32. Muenchhoff M, Prendergast AJ, Goulder PJ. Immunity to HIV in early life. Frontiers in Immunology. 2014;5:391. http://dx.doi.org/10.3389/fimmu.2014.00391
33. van den Berg JP, Westerbeek EA, van der Klis FR, Berbers GA, van Elburg RM. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev. 2011;87:67–72. http://dx.doi.org/10.1016/j.earlhumdev.2010.11.003
34. Feikin DR, Scott JA, Gessner BD. Use of vaccines as probes to define disease burden. Lancet. 2014;383:1762–70. http://dx.doi.org/10.1016/S0140-6736(13)61682-7
35. Tolockiene E, Morsing E, Holst E, Herbst A, Ljungh A, Svenningsen N, et al. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand. 2001;80:511–8. http://dx.doi.org/10.1034/j.1600-0412.2001.080006511.x